• triple negative breast cancer clinical trials and studies 2025: openPR.com Tue, 25 Mar 2025 13:54:00 GMT
• bladder cancer clinical trials and studies 2025: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Tue, 25 Mar 2025 07:00:00 GMT
• g1 therapeutics, inc. reports earnings results for the fourth quarter and full year ended december 31, 2023 Marketscreener.com Sun, 02 Mar 2025 18:54:23 GMT
• triple negative breast cancer (tnbc) market, clinical trials, fda approval, medication and companies, EIN News Mon, 20 Jan 2025 03:50:00 GMT
• g1 therapeutics to participate virtually in the h.c. wainwright 24th annual global investment conference Marketscreener.com Sat, 11 Jan 2025 19:01:14 GMT
• small drug developer seeks $100m for new cancer treatment The Business Journals Fri, 20 Dec 2024 12:59:00 GMT
• Drug developer seeks $100M for new cancer treatment The Business Journals Fri, 20 Dec 2024 08:00:00 GMT
• earnings flash (gthx) g1 therapeutics posts q3 revenue $12.3m, vs. street est of $14.2m Marketscreener.com Wed, 04 Dec 2024 02:34:32 GMT
• g1 therapeutics completes enrollment in global multi-center phase 3 clinical trial of trilaciclib in patients with metastatic trip... Marketscreener.com Sat, 23 Nov 2024 18:39:45 GMT
• g1 therapeutics, inc. announces management changes Marketscreener.com Thu, 21 Nov 2024 09:48:38 GMT
• earnings flash (gthx) g1 therapeutics reports q1 revenue $12.9m, vs. street est of $11.4m Marketscreener.com Mon, 04 Nov 2024 04:04:53 GMT
• g1 therapeutics, inc. announces executive changes Marketscreener.com Sat, 02 Nov 2024 11:15:18 GMT
• er+/ her2 -ve breast cancer pipeline therapeutics, assessment, companies, products, unmet needs, market drivers and barriers The Globe and Mail Wed, 23 Oct 2024 22:14:31 GMT
• colorectal cancer pipeline overview 2024: fda approvals and key companies involved by delveinsight | novartis, pharma oncology, pu... The Globe and Mail Mon, 21 Oct 2024 14:39:45 GMT
• needham adjusts price target on g1 therapeutics to $32 from $42, reiterates buy rating Marketscreener.com Sun, 20 Oct 2024 12:53:45 GMT
• hc wainwright adjusts g1 therapeutics price target to $57 from $67, maintains buy rating Marketscreener.com Sun, 20 Oct 2024 04:54:15 GMT
• pharmacosmos ventures into oncology and merges with g1 therapeutics MSN Thu, 17 Oct 2024 13:01:12 GMT
• executives on the move: leadership changes & insights | scrip Citeline Tue, 15 Oct 2024 07:38:38 GMT
• g1 therapeutics says study confirms myelosuppression risk in patients getting chemotherapy for lung cancer Marketscreener.com Mon, 14 Oct 2024 22:12:06 GMT
• g1 therapeutics says phase 2 trial shows objective response rate of 40% in patients with bladder cancer Marketscreener.com Thu, 10 Oct 2024 21:38:23 GMT
• needham adjusts price target on g1 therapeutics to $31 from $32, maintains buy rating Marketscreener.com Wed, 09 Oct 2024 12:17:00 GMT
• g1 therapeutics : to provide second quarter 2020 corporate and financial update on august 5, 2020 Marketscreener.com Tue, 08 Oct 2024 10:48:29 GMT
• g1 therapeutics to end colorectal cancer trial of drug therapy; shares plunge Marketscreener.com Fri, 04 Oct 2024 17:11:53 GMT
• contact for years: how pharmacosmos secured us cancer company in triple-digit million-dollar deal MedWatch Tue, 01 Oct 2024 07:00:00 GMT
• g1 therapeutics says trilaciclib shows potential for improved clinical outcome in phase 2 breast cancer trial Marketscreener.com Tue, 01 Oct 2024 03:08:42 GMT
• executives on the move: a new ceos for acadia pharmaceuticals and g1 therapeutics among this week's changes Scrip Thu, 26 Sep 2024 07:00:00 GMT
• global cancer rates surge as biotech innovators work on new therapies Quantisnow Fri, 20 Sep 2024 07:00:00 GMT
• pharmacosmos after major acquisition: “the next six months are about integrating g1 well” MedWatch Thu, 19 Sep 2024 07:00:00 GMT
• g1 therapeutics, pharmacosmos announce closing of tender offer TipRanks Wed, 18 Sep 2024 13:05:10 GMT
• Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer GlobeNewswire Wed, 18 Sep 2024 07:00:00 GMT
• pharmacosmos acquires g1 therapeutics, enhances cancer therapy reach TipRanks Wed, 18 Sep 2024 07:00:00 GMT
• why g1 therapeutics inc [gthx] is a good choice for investors after new price target of $7.15 The DBT News Tue, 17 Sep 2024 21:03:52 GMT
• g1 therapeutics inc: navigating a turbulent year, up -0.70% from 52-week low The InvestChronicle Mon, 16 Sep 2024 19:04:21 GMT
• gpt-o1 preview from openai – a step towards agi? The Currency Journal Mon, 16 Sep 2024 14:26:41 GMT
• acadian asset management llc increases stake in g1 therapeutics, inc. (nasdaq:gthx) MarketBeat Sun, 15 Sep 2024 10:32:50 GMT
• acadian asset management llc boosts stock position in g1 therapeutics, inc. (nasdaq:gthx) MarketBeat Sun, 15 Sep 2024 10:32:50 GMT
• exploring high growth tech stocks in the united states for september 2024 Yahoo Finance Mon, 09 Sep 2024 10:02:54 GMT
• gthx - g1 therapeutics, inc. latest stock news & market updates StockTitan Thu, 05 Sep 2024 22:16:10 GMT
• g1 therapeutics, pharmacosmos announce expiration of hsr waiting period TipRanks Thu, 05 Sep 2024 11:13:29 GMT
• Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period GlobeNewswire Thu, 05 Sep 2024 07:00:00 GMT
• pharmacosmos moves forward with g1 therapeutics buyout Investing.com Thu, 05 Sep 2024 07:00:00 GMT
• panagora asset management inc. buys new shares in g1 therapeutics, inc. (nasdaq:gthx) MarketBeat Wed, 04 Sep 2024 08:37:56 GMT
• 177,051 shares in g1 therapeutics, inc. (nasdaq:gthx) acquired by panagora asset management inc. MarketBeat Wed, 04 Sep 2024 08:37:56 GMT
• biopharma layoff tracker 2024: biomarin, repare, genentech and more cut staff BioSpace Fri, 30 Aug 2024 07:00:00 GMT
• gthx stock soars to 52-week high, reaching $7.12 amidst 313% annual surge Investing.com India Sat, 24 Aug 2024 07:00:00 GMT
• gthx stock soars to 52-week high, reaching $7.12 amidst 313% annual surge Investing.com Fri, 23 Aug 2024 20:35:19 GMT
• biopharma layoff tracker 2024: aadi, lykos, galera and more cut staff BioSpace Thu, 22 Aug 2024 07:00:00 GMT
• biopharma layoff tracker 2024: lykos, galera, grail and more cut staff BioSpace Tue, 20 Aug 2024 22:43:36 GMT
• incyclix bio appoints dr. andrew beelen as vice president of clinical development citybiz Tue, 20 Aug 2024 07:00:00 GMT
• biopharma layoff tracker 2024: bayer, tome, aadi and more cut staff BioSpace Mon, 19 Aug 2024 07:00:00 GMT
• biopharma layoff tracker 2024: aadi, lykos, galera and more cut staff BioSpace Mon, 19 Aug 2024 07:00:00 GMT
• biopharma layoff tracker 2024: lykos, galera, grail and more cut staff BioSpace Mon, 19 Aug 2024 07:00:00 GMT
• g1 therapeutics, inc. (nasdaq:gthx) position raised by vanguard group inc. MarketBeat Fri, 16 Aug 2024 11:30:45 GMT
• g1 therapeutics, inc. (nasdaq:gthx) shares purchased by vanguard group inc. MarketBeat Fri, 16 Aug 2024 11:30:45 GMT
• vanguard group inc. raises stock holdings in g1 therapeutics, inc. (nasdaq:gthx) Defense World Fri, 16 Aug 2024 10:34:20 GMT
• brodsky & smith shareholder update: notifying investors of GlobeNewswire Thu, 15 Aug 2024 07:00:00 GMT
• gthx stock soars to 52-week high, hits $7.1 amid growth Investing.com Thu, 15 Aug 2024 07:00:00 GMT
• biopharma layoff tracker 2024: galera, grail, viracta and more cut staff BioSpace Thu, 15 Aug 2024 07:00:00 GMT
• pharmacosmos ventures into oncology and merges with g1 therapeutics MSN Thu, 15 Aug 2024 00:03:34 GMT
• pharmacosmos group’s acquisition of g1 therapeutics Global Legal Chronicle Mon, 12 Aug 2024 07:00:00 GMT
• q3 2024 eps estimates for g1 therapeutics, inc. lifted by analyst (nasdaq:gthx) MarketBeat Mon, 12 Aug 2024 07:00:00 GMT
• q3 2024 eps estimates for g1 therapeutics, inc. (nasdaq:gthx) raised by analyst Defense World Mon, 12 Aug 2024 06:54:14 GMT
• wedbush research analysts increase earnings estimates for g1 therapeutics, inc. (nasdaq:gthx) MarketBeat Mon, 12 Aug 2024 06:23:28 GMT
• g1 therapeutics, inc. (nasdaq:gthx) expected to earn q3 2025 earnings of ($0.04) per share Defense World Sat, 10 Aug 2024 23:40:11 GMT
• g1 therapeutics (nasdaq:gthx) issues quarterly earnings results, beats estimates by $0.07 eps Defense World Sat, 10 Aug 2024 16:15:25 GMT
• wedbush equities analysts cut earnings estimates for g1 therapeutics, inc. (nasdaq:gthx) MarketBeat Fri, 09 Aug 2024 14:19:54 GMT
• g1 therapeutics, inc. to post q3 2025 earnings of ($0.04) per share, wedbush forecasts (nasdaq:gthx) MarketBeat Fri, 09 Aug 2024 14:19:54 GMT
• g1 therapeutics (nasdaq:gthx) rating reiterated by needham & company llc Defense World Fri, 09 Aug 2024 11:40:02 GMT
• hc wainwright lowers g1 therapeutics (nasdaq:gthx) to hold MarketBeat Fri, 09 Aug 2024 11:24:17 GMT
• fy2027 earnings estimate for g1 therapeutics, inc. (nasdaq:gthx) issued by wedbush Defense World Fri, 09 Aug 2024 08:47:40 GMT
• G1 Therapeutics (GTHX) Shares Surge Following Acquisition Announcement fostersleader.com Fri, 09 Aug 2024 07:00:00 GMT
• g1 therapeutics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price ... Business Wire Fri, 09 Aug 2024 07:00:00 GMT
• g1 therapeutics (nasdaq:gthx) stock rating lowered by wedbush MarketBeat Thu, 08 Aug 2024 15:31:18 GMT
• g1 therapeutics, inc. (nasdaq:gthx) forecasted to earn fy2027 earnings of $0.16 per share MarketBeat Thu, 08 Aug 2024 13:59:39 GMT
• Pharmacosmos ventures into oncology and merges with G1 Therapeutics Pharmaceutical Technology Thu, 08 Aug 2024 07:00:00 GMT
• After stumble in trials, Durham cancer drugmaker goes private in $405 million deal Raleigh News & Observer Thu, 08 Aug 2024 07:00:00 GMT
• In $400M deal for Triangle firm, familiar name is largest shareholder The Business Journals Thu, 08 Aug 2024 07:00:00 GMT
• g1 therapeutics provides second quarter 2024 financial results and operational highlights GlobeNewswire Thu, 08 Aug 2024 07:00:00 GMT
• g1 therapeutics inc (gthx) q2 2024 earnings: eps of $(0.10) beat GuruFocus.com Thu, 08 Aug 2024 07:00:00 GMT
• g1 therapeutics (gthx) reports q2 loss, tops revenue estimates Yahoo Finance Thu, 08 Aug 2024 07:00:00 GMT
• brodsky & smith shareholder update: notifying investors of GlobeNewswire Thu, 08 Aug 2024 07:00:00 GMT
• fy2027 eps estimates for g1 therapeutics, inc. (nasdaq:gthx) boosted by wedbush MarketBeat Thu, 08 Aug 2024 07:00:00 GMT
• biopharma layoff tracker 2024: entero, precigen, sumitomo and more cut staff BioSpace Thu, 08 Aug 2024 07:00:00 GMT
• shareholder alert: ademi llp investigates whether g1 therapeutics, inc. has obtained a fair price for its public shareholders The Malaysian Reserve Thu, 08 Aug 2024 06:55:26 GMT
• g1 therapeutics sees unusually large options volume (nasdaq:gthx) Defense World Thu, 08 Aug 2024 05:13:23 GMT
• g1 therapeutics (nasdaq:gthx) stock rating reaffirmed by needham & company llc MarketBeat Thu, 08 Aug 2024 02:18:07 GMT
• path forward for cancer biotech g1 therapeutics is $405m acquisition by pharmacosmos MedCity News Thu, 08 Aug 2024 00:07:09 GMT
• g1 therapeutics (nasdaq:gthx) stock rating reaffirmed by needham & company llc MarketBeat Wed, 07 Aug 2024 23:01:59 GMT
• pharmacosmos group to acquire g1 therapeutics for $7.15 per share TipRanks Wed, 07 Aug 2024 18:33:45 GMT
• investors purchase high volume of call options on g1 therapeutics (nasdaq:gthx) MarketBeat Wed, 07 Aug 2024 17:25:38 GMT
• g1 therapeutics target of unusually high options trading (nasdaq:gthx) MarketBeat Wed, 07 Aug 2024 17:25:38 GMT
• danish company to acquire g1 therapeutics in deal worth $405m Business North Carolina Wed, 07 Aug 2024 15:40:44 GMT
• Pharmacosmos picks up G1 Therapeutics, FDA-approved drug Cosela in merger worth $405M Fierce Pharma Wed, 07 Aug 2024 07:00:00 GMT
• Pharmacosmos to acquire G1 Therapeutics | Pharmaceutical | The Pharmaletter The Pharma Letter Wed, 07 Aug 2024 07:00:00 GMT
• Path Forward for Cancer Biotech G1 Therapeutics Is $405M Acquisition by Pharmacosmos MedCity News Wed, 07 Aug 2024 07:00:00 GMT
• Danish company to acquire G1 Therapeutics for $405M Business North Carolina Wed, 07 Aug 2024 07:00:00 GMT
• private danish iron deficiency biotech to buy g1 therapeutics for $405m Endpoints News Wed, 07 Aug 2024 07:00:00 GMT
• gthx stock alert: halper sadeh llc is investigating whether the sale of g1 therapeutics, inc. is fair to shareholders Business Wire Wed, 07 Aug 2024 07:00:00 GMT
• g1 therapeutics stock surges on merger deal (nasdaq:gthx) Seeking Alpha Wed, 07 Aug 2024 07:00:00 GMT
• shareholder alert: ademi llp investigates whether g1 therapeutics, inc. has obtained a fair price for its public shareholders PR Newswire Wed, 07 Aug 2024 07:00:00 GMT
• g1 therapeutics acquisition and executive compensation revamp TipRanks Wed, 07 Aug 2024 07:00:00 GMT
• pharmacosmos group to acquire g1 therapeutics | gthx stock news StockTitan Wed, 07 Aug 2024 07:00:00 GMT
• rtp company taken private in $405 million deal The Business Journals Wed, 07 Aug 2024 07:00:00 GMT
• denmark's pharmacosmos to buy g1 therapeutics for $405 million MarketWatch Wed, 07 Aug 2024 07:00:00 GMT
• g1 therapeutics shares hit 52-week high on deal to be acquired MarketWatch Wed, 07 Aug 2024 07:00:00 GMT
• pharmacosmos to acquire g1 therapeutics for $405 million Investing.com Wed, 07 Aug 2024 07:00:00 GMT
• 2024-08-07 | shareholder alert: ademi llp investigates whether g1 therapeutics, inc. has obtained a fair price for its public shar... Stockhouse Publishing Wed, 07 Aug 2024 07:00:00 GMT
• g1 therapeutics downgraded to neutral from buy at rodman & renshaw TipRanks Wed, 07 Aug 2024 07:00:00 GMT
• g1 therapeutics upgraded to neutral from underweight at jpmorgan TipRanks Wed, 07 Aug 2024 07:00:00 GMT
• g1 therapeutics downgraded to neutral from outperform at wedbush TipRanks Wed, 07 Aug 2024 07:00:00 GMT
• g1 therapeutics (gthx) scheduled to post quarterly earnings on thursday American Banking and Market News Tue, 06 Aug 2024 16:22:55 GMT
• g1 therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) GlobeNewswire Fri, 02 Aug 2024 07:41:44 GMT
• g1 therapeutics (gthx) to release quarterly earnings on thursday Defense World Thu, 01 Aug 2024 09:14:57 GMT
• g1 therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) GlobeNewswire Thu, 01 Aug 2024 07:00:00 GMT
G1 Therapeutics, Inc(NASDAQ:GTHX) 
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult ...
Website: http://www.g1therapeutics.com
Founded: 2008
Full Time Employees: 104
Sector: Healthcare
Industry: Biotechnology